Cargando…
A Targeted Mass Spectrometry Approach to Identify Peripheral Changes in Metabolic Pathways of Patients with Alzheimer’s Disease
Alzheimer’s disease (AD), a neurodegenerative disorder, is the most common cause of dementia in the elderly population. Since its original description, there has been intense debate regarding the factors that trigger its pathology. It is becoming apparent that AD is more than a brain disease and har...
Autores principales: | Reveglia, Pierluigi, Paolillo, Carmela, Angiolillo, Antonella, Ferretti, Gabriella, Angelico, Ruggero, Sirabella, Rossana, Corso, Gaetano, Matrone, Carmela, Di Costanzo, Alfonso |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253805/ https://www.ncbi.nlm.nih.gov/pubmed/37298687 http://dx.doi.org/10.3390/ijms24119736 |
Ejemplares similares
-
Challenges in LC–MS-based metabolomics for Alzheimer’s disease early detection: targeted approaches versus untargeted approaches
por: Reveglia, Pierluigi, et al.
Publicado: (2021) -
Tandem Mass Spectrometry as Strategy for the Selective Identification and Quantification of the Amyloid Precursor Protein Tyr682 Residue Phosphorylation Status in Human Blood Mononuclear Cells
por: Reveglia, Pierluigi, et al.
Publicado: (2021) -
An increase in Semaphorin 3A biases the axonal direction and induces an aberrant dendritic arborization in an in vitro model of human neural progenitor differentiation
por: Ferretti, Gabriella, et al.
Publicado: (2022) -
Fyn Tyrosine Kinase Elicits Amyloid Precursor Protein Tyr682 Phosphorylation in Neurons from Alzheimer’s Disease Patients
por: Iannuzzi, Filomena, et al.
Publicado: (2020) -
Blood biomarkers indicate that the preclinical stages of Alzheimer's disease present overlapping molecular features
por: Di Costanzo, Alfonso, et al.
Publicado: (2020)